Alisertib promotes apoptosis and autophagy in melanoma through p38 MAPK-mediated aurora a signaling

We investigated the efficacy of Alisertib (ALS), a selective Aurora kinase A (AURKA) inhibitor, in melanoma. We found that ALS exerts anti-proliferative, pro-apoptotic, and pro-autophagic effects on A375 and skmel-5 melanoma cells by inhibiting p38 MAPK signaling. SB202190, a p38 MAPK-selective inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Yuan-Yuan, Yao, Ming, Zhou, Zhi-Wei, Jian-Cui, Li-Xia, Hu, Rong-Ying, Yu, Ying-Yao, Qiong-Gao, Biao-Yang, Liu, Yu-Xi, Dang, Jie, Zhou, Shu-Feng, Nan-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739797/
https://www.ncbi.nlm.nih.gov/pubmed/29291012
http://dx.doi.org/10.18632/oncotarget.22328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739797/
https://www.ncbi.nlm.nih.gov/pubmed/29291012
http://dx.doi.org/10.18632/oncotarget.22328

Ejemplares similares